Author Archives: Patricia Inacio PhD

Expert Analysis Updates Advice on Managing Sickle Cell Retinopathy

Following a review of studies published in the last decade, experts have updated their recommendations for managing a sickle cell disease-related eye complication known as sickle cell retinopathy (SCR). Their paper, “Sickle cell retinopathy: improving care with a multidisciplinary approach,” appeared in the Journal of Multidisciplinary Healthcare. SCR, a…

AbbVie’s Imbruvica is First Approved Treatment for Adults with Chronic Graft-Versus-Host-Disease

The U.S. Food and Drug Administration (FDA) approved Imbruvica (ibrutinib) for treatment of adult patients with chronic graft-versus-host-disease (cGVHD) who failed to respond to other forms of systemic therapy, AbbVie announced. FDA’s decision means Imbruvica is the first and only therapy specifically approved for adults with cGVHD, a serious outcome that…